SLACOM - Sociedad Latinoamericana y del Caribe de Oncología Médica
   • Medical Issues
   • Clinical Research
   • Educational Activities
   • Guidelines
   • Observatory
   • SLACOM-BCRF Project
Scientific & Educational Issues
Medical Issues

Revision on breast cancer in Latin America
Synopsis Prepared by: Nahila Justo, i3 Innovus, Nils Wilking, Karolinska Institutet, Bengt Jönsson, Stockholm School of Economics

This revision on breast cancer in Latin America to be published in November 2010 discloses that this study aims at determining the results, cares and costs of breast cancer in eleven countries of Latin America.
With 114.000 new cases and 37.000 deaths per year, breast cancer is the most frequent neoplasia in Latin America and the Caribbean.
There exists a great disparity according to the different countries: in Argentina and Uruguay the incidence is five to six times higher than in Mexico and Panamá; in Colombia, Brazil and Perú they are diagnosed in advanced phases that cause greater costs and worse results.  In others, many diagnoses in young women.
The WHO estimated that if the incidence keeps up, in 2030 there will be 850.000 deaths due to this in women between 29 and 69 years old.
As an example: the Mexican Social Security informs that each patient consumes the equivalent to US$7.386 in phase I, US$10.113 in phase II, US$15.265 in phase III and US$19.750 in phase IV. The social security agency in Costa Rica informed that they invest US$10.172 per patient with breast cancer per year.  The President of Brazilian Oncology Society mentioned that the Unique Health System of Brazil invests US$4.600 per each patient with breast cancer per year. It is to be noted that the new treatments for breast cancer such as Trastuzumab or Aromatasa inhibitors are not covered in several countries, for example: in Brazil social security does not cover Trastuzumab nor Lapatinib; in Chile it’s been only three months that the cover Trastuzumab; in Perú, more than 31% of the population does not have access to social security.
There is much slowness in completing the cancer registries and in adopting appropriate conducts internationally accepted.
To read the full document see attachment.

Attached Files
Full document
Copyright © 2008 SLACOM. All rights reserved.
Developed by: Unlimited ideas